In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Anti-thrombotic prevention and treatment in Type 2 Diabetes Mellitus

Webinar from the ESC Working Groups on Thrombosis and Aorta & Peripheral Vascular Diseases

Add to calendar23/01/201818:00 23/01/201819:00 Europe/Paris Anti-thrombotic prevention and treatment in Type 2 Diabetes Mellitus ESC Working Group on Thrombosis, ESC Working Group on Aorta & Peripheral Vascular Diseases DD/MM/YYYY
ESC Working Group on Thrombosis
Diabetes and the Heart
Aortic Disease
Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Vascular Biology and Physiology
Risk Factors and Prevention
Cardiovascular Pharmacotherapy
Venous Thromboembolism
Aortic Disease, Peripheral Vascular Disease, Stroke

Focus on

Learning Objectives:

By attending this Webinar the participants will learn:

  • To illustrate the characteristics of platelet activation and the clinical pharmacology of anti-thrombotic drugs in patients with diabetes
  • To offer an overview of the available evidence on anti-thrombotic therapies in diabetic patients with CAD and/or PAD
  • To discuss the unmet clinical needs regarding anti-thrombotic therapy in patients with diabetes

Watch the webinar recording




 vlachopoulos_charalambos-2015.jpgAssociate Professor Vlachopoulos Charalambos, FESC
Hippokration Hospital
1St Cardiology Department
Athens, Greece

Rocca-Bianca-2016.jpgAssociate Professor Bianca Rocca 
Catholic University School Of Medicine
Rome, Italy 



Professor Victor Aboyans, FESC
CHRU Dupuytren Limoges
Limoges, France

 Session information

 This webinar addresses:

  • General cardiologists
  • Cardiologists specialising in Peripheral Artery Diseases (PAD) and Coronary Artery Diseases (CAD) where in-depth coverage of all relevant conditions
  • Cardiologists, General Internal doctors and specialists in angiology, pharmacotherapy, interventional cardiologists and electrophysiologists dealing with atrial fibrillation
  • Clinical cardiologists, who would benefit from access to specific courses relating to PAD & CAD.
  • Physicians involved in diagnosis and care of PAD & CAD

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide feedback live.

 Technical settings

The webinar is available on PC and Tablets. The use of a smartphone is not recommended. For the best viewing experience, a high-speed Internet connection is required (minimum 2 Mbps).

Please make sure that the firewall does not prevent the connection to the webinar.